Algiax Pharmaceuticals

Disarming chronic neuropathic pain

Founded 2011 Germany

Erkrath, Germany 5 employees Total: $4.30M Biotechnology, Health Care +1

Algiax Pharmaceuticals is an independent biotechnology company founded in 2011 and based in Germany. The company is dedicated to disarming chronic neuropathic pain, with a strong focus on neuropathic pain and acute spinal cord injury within the nervous system disease field. Their lead candidate AP-325 is currently in clinical development for the treatment of neuropathic pain, while new chemical entities such as AP-4 & AP-8 are in preclinical development for the treatment of Diabetes Type 1. Algiax's strategy revolves around developing its drug candidates up to a Clinical Phase II-III stage and then out-licensing them to pharmaceutical and biotech companies for further clinical development and market authorization. In September 2019, the company received a Non-Equity Assistance investment from VentureOut. Algiax Pharmaceuticals' dedication to tackling high unmet medical needs through innovative product development, particularly in the treatment of chronic neuropathic pain, positions it as a promising player in the biotechnology and pharmaceutical industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Support Program	Undisclosed	1	VentureOut Fund	01 Sep 2019
Series A	€4.30M	-		01 May 2012

Funding Stage

Amount

Investors

Lead Investors

Date

Support Program

Undisclosed

VentureOut Fund

01 Sep 2019

Series A

€4.30M

01 May 2012

FAQ About Algiax Pharmaceuticals

Disarming chronic neuropathic pain

Algiax Pharmaceuticals was founded in 2011.

Algiax Pharmaceuticals is headquartered in Erkrath, Germany.

Algiax Pharmaceuticals operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Algiax Pharmaceuticals GmbH, biotechnology company, neuropathic pain and acute spinal cord injury.

Algiax Pharmaceuticals has approximately 5 employees.

Algiax Pharmaceuticals has completed 2 funding rounds, raising a total of $4.30M.

Top alternatives and competitors to Algiax Pharmaceuticals include Hoba Therapeutics, NeuroTherapia, Inc., Cavion, Tolerx, Inc., MediciNova. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Algiax Pharmaceuticals and Hoba Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Algiax Pharmaceuticals

Funding Rounds & Investors (2)

Algiax Pharmaceuticals Alternatives & Competitors

FAQ About Algiax Pharmaceuticals